Pathogenesis of hypersensitivity pneumonitis

Current Opinion in Allergy and Clinical Immunology

Volumn 4, Issue 2, 2004, Pages 93-98

  Girard, Melissa ^a   Israël Assayag, Evelyne ^a   Cormier, Yvon ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Extrinsic allergic alveolitis; Lung inflammation; Respiratory disease

Indexed keywords

ANTIGEN;

ALLERGIC PNEUMONITIS; HUMAN; IMMUNE RESPONSE; INFLAMMATORY CELL; MEDIATOR RELEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ALVEOLITIS, EXTRINSIC ALLERGIC; ANIMALS; CELL ADHESION; CHEMOKINES; CYTOKINES; EXTRACELLULAR MATRIX; FREE RADICALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; SMOKING;

EID: 2342468798     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200404000-00004     Document Type: Review

References (47)

1. Schuyler M, Gott K, Cherne A. Mediators of hypersensitivity pneumonitis. J Lab Clin Med 2000; 136:29-38.
2. Selman M. Hypersensitivity pneumonitis. In: Schwartz MI, King TE, editors. Interstitial lung disease. 3rd ed. Hamilton, BC: Decker Inc.; 1998. pp. 393-422.
3. Patel AM, Ryu JH, Reed CE. Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol 2001; 108:661-670.
4. Cormier Y, Israël-Assayag E. Pathogenesis of hypersensitivity pneumonitis. In: Textbook of respiratory cell and molecular biology. 1st ed. London: Martin Dunitz Ltd; 2002. pp. 147-158. This book chapter relates the involvement of inflammatory cells, antigen-specific antibodies and inflammatory mediators in the pathogenesis of hypersensitivity pneumonitis.
5. Yi ES. Hypersensitivity pneumonitis. Crit Rev Clin Lac Sci 2002; 39:581-629. A comprehensive review of hypersensitivity pneumonitis including an interesting section on its pathogenesis with emphasis on alveolar macrophages, viral infection and mediators.
6. Murin S, Smith BK, Matthay R. Other smoking-affected pulmonary diseases. Clin Chest Med 2000; 21:121-137.
7. Lacasse Y, Selman M, Costabel U, et al. Clinical diagnosis of hypersensitivity pneumonitis. Am J Crit Care Med 2003; 168:952-958.
8. Delacourt C. Extrinsic allergic alveolitis. Arch Pediatr 1999; 6 (Suppl 1):83S-86S.
9. McSharry C, Anderson K, Bourke SJ, Boyd G. Takes your breath away: the immunology of allergic alveolitis. Clin Exp Immunol 2002; 128:3-9. A well structured review on the immunological factors believed to operate in the pathogenesis of hypersensitivity pneumonitis.
10. Yamamoto Y, Osanai S, Fujiuchi S, et al. Saccharomyces-induced hypersensitivity pneumonitis in a dairy farmer: a case report. Nihon Kokyuki Gakkai Zasshi 2002; 40:484-488.
11. Martin-Garcia C, Hinojosa M, Porcel S, et al. Corn-induced hypersensitivity pneumonitis. Allergy 2003; 58:534-535.
12. Aksamit TR. Hot tub lung: infection, inflammation, or both? Semin Respir Infect 2003; 18:33-39.
13. Rickman OB, Ryu JH, Fidler ME, Kalra S. Hypersensitivity pneumonitis associated with Mycobacterium avium complex and hot tub use. Mayo Clin Proc 2002; 77:1233-1237.
14. Wallace RJ, Zhang Y, Wilson RW, et al. Presence of a single genotype of the newly described species Mycobaterium immunogenum in industrial metalworking fluids associated with hypersensitivity pneumonitis. Appl Env Microbiol 2002; 68:5580-5584.
15. Falkinham JO. Mycobacterial aerosols and respiratory diseases. Emerg Infect Dis 2003; 9:763-767.
16. Cappelluti E, Fraire AE, Schaefer OP. A case of 'hot tub lung' due to Mycobacterium avium complex in a immunocompetent host. Arch Intern Med 2003; 163:845-848.
17. Falkinham JO. Nontuberculous mycobacteria in the environment. Clin Chest Med 2002; 23:529-551.
18. Kita T, Nishi K, Fujimura M, et al. A case of hypersensitivity pneumonitis by Humicola fuscoatra. Respirology 2003; 8:95-98.
19. Yamamoto Y, Osanai S, Fujiuchi S, et al. Extrinsic allergic alveolitis induced by the yeast Debaryomyces hansenii. Eur Respir J 2002; 20:1351-1353.
20. Ikeda T, Kuroda M, Ueshima K. A case of hypersensitivity pneumonitis caused by Gyrodontium versicolor. Nihon Kokyuki Gakkai Zasshi 2002; 40:387-391.
21. Sakai Y, Hisauchi KK, Umino T, et al. Purification and characterization of the allergenic components of shimeji mushroom (Tricholoma conglobatum) spore for shimeji workers' hypersensitivity pneumonitis. J Med Dent Sci 2000; 47:67-75.
22. Israël-Assayag E, Dakhama A, Lavigne S, et al. Expression of costimulatory molecules on alveolar macrophages in hypersensitivity pneumonitis. Am J Crit Care Med 1999; 159:1830-1834.
23. Laflamme C, Israël-Assayag E, Cormier Y. Apoptosis of bronchoalveolar lavage lymphocytes in hypersensitivity pneumonitis. Eur Respir J 2003; 21:225-231. An interesting study suggesting a role of decreased lung lymphocytes apoptosis in the lymphocytosis involved in hypersensitivity pneumonitis.
24. Drent M, Grutters JC, Mulder PG, et al. Is the different T helper cell activity in sarcoidosis and extrinsic allergic alveolitis also reflected by the cellular bronchoalveolar lavage fluid profile? Sarcoidosis Vasc Diffuse Lung Dis 1997; 14:31-38.
25. Grubek-Jaworska H, Hoser G, Droszcz P, Chazan R. CD4/CD8 lymphocytes in BALF during the efferent phase of lung delayed-type hypersensitivity reaction induced by a single antigen inhalation. Med Sci Monit 2001; 7:878-883.
26. Irifune K, Yokoyama A, Kohno N, et al. T-helper 1 cells induce alveolitis but do not lead to pulmonary fibrosis in mice. Eur Respir J 2003; 21:11-18. A well conducted study showing differences between acute and chronic forms of hypersensitivity pneumonitis.
27. Tibério IF, Leick-Maldonado EA, Miyahara L, et al. Effects of neurokinins on airway and alveolar eosinophil recruitment. Exp Lung Res 2003; 29:165-177. By focusing on a possible role of eosinophils in hypersensitivity pneumonitis, this paper shows that neurokinis may contribute to eosinophilic inflammation.
28. Denis M, Bédard M, Laviolette M, Cormier Y. A study in monokines release and natural killer activity in the bronchoalveolar lavage of subjects with farmer's lungs. Am Rev Respir Dis 1993; 147:934-939.
29. Popper HH, Pailer S, Wurzinger G, et al. Expression of adhesion molecules in allergic lung disease. Virchows Arch 2002; 440:172-180.
30. Wilson E, Aydintug MK, Jutila MA. A circulating bovine γδ T cell subset, which is found in large numbers in the spleen, accumulates inefficiently in an artificial site of inflammation: correlation with lack of expression of E-selectin ligands and L-selectin. J Immunol 1999; 162:4914-4919.
31. Pan LH, Yamauchi K, Sawai T, et al. Inhibition of binding of E- and P-selectin to sialyl-lewis X molecule suppresses the inflammatory response in hypersensitivity pneumonitis in mice. Am J Crit Care Med 2000; 161:1689-1697.
32. Navarro C, Mendoza F, Barrera L, et al. Up-regulation of L-selectin and E-selectin in hypersensitivity pneumonitis. Chest 2002; 121:354-360. A well performed study showing that selectins may contribute to the increased traffic of lung inflammatory cells.
33. Fujimori Y, Kataoka M, Tada S, et al. The role of interleukin-8 in interstitial pneumonia. Respirology 2003; 8:33-40.
34. Denis M. Proinflammatory cytokines in hypersensitivity pneumonitis. Am J Respir Crit Care Med 1995; 151:164-169.
35. Schuyler M, Gott K, Cherne A. Experimental hypersensitivity pneumonitis: role of MCP-1. J Lab Clin Med 2003; 142:187-195.
36. Pardo A, Smith KM, Abrams J, et al. CCL18/DC-CK-1/PARC up-regulation in hypersensitivity pneumonitis. J Leukoc Biol 2001; 70:610-616.
37. Butler NS, Monick MM, Yarovinsky TO, et al. Altered IL-4 mRNA stability correlates with Th1 and Th2 bias and susceptibility to hypersensitivity pneumonitis in two inbred strains of mice. J Immunol 2002; 169:3700-3709. A comprehensive study on correlation of the mRNA stability of IL-4 and the severity of the disease.
38. Schuyler M, Gott K, Cherne A. Is IL-12 necessary in experimental hypersensitivity pneumonitis? Int J Exp Path 2002; 83:87-98.
39. Sumi Y, Kyi M, Miyazaki Y, et al. Cytokine mRNA expression in isocyanate-induced hypersensitivity pneumonitis. Respiration 2003; 70:284-291.
40. Lakari E, Soini Y, Säily M, et al. Inducible nitric oxide synthase, but not xanthine oxidase, is highly expressed in interstitial pneumonias and granulomatous diseases of human lung. Am J Clin Pathol 2002; 117:132-142.
41. Fujimoto H, Gabazza EC, Hataji O, et al. Thrombin-activable fibrinolysis inhibitor and protein C inhibitor in interstitial lung disease. Am J Crit Care Med 2003; 167:1687-1694.
42. Yamaguchi E, Itoh A, Furuya K, et al. Release of tumor necrosis factor-alpha from human alveolar macrophages is decreased in smokers. Chest 1993; 103:479-483.
43. Blanchet MR, Israël-Assayag E, Cormier Y. Inhibitory effect of nicotine on experimental hypersensitivity pneumonitis in vivo and in vitro. Am J Respir Crit Care Med 2003; Epub ahead of print.
44. Ohtsuka Y, Munakata M, Tanimura K, et al. Smoking promotes insidious and chronic farmer's lung disease, deteriorates the clinical outcome. Intern Med 1995; 34:966-971.
45. Dakhama A, Hegele RG, Laflamme G, et al. Common respiratory viruses in lower airways of patients with acute hypersensitivity pneumonitis. Am J Crit Care Med 1999; 159:1316-1322.
46. Cormier Y, Israël-Assayag E. The role of viruses in the pathogenesis of hypersensitivity pneumonitis. Curr Opin Pulm Med 2000; 6:420-423.
47. Camarena A, Juarez A, Mejia M, et al. Major histocompatibility complex and tumor necrosis factor-α polymorphism in pigeon breeder's disease. Am J Respir Crit Care Med 2001; 163:1528-1533.